Mirus' 3D Transfection System is designed for transfecting cells propagated in 3D cell culture.
The system combines the technologies of Reinnervate’s alvetex 3D cell culture
plates and Mirus Bio’s TransIT-3D Transfection Reagent, enabling scientists
to conduct research that more accurately mimics the tissue environment. The
system achieves high expression in a wide range of cell types grown in 3D
culture, has a user-friendly protocol that requires minimal optimization,
and is compatible with solid matrix scaffold and hydrogel 3D culture
Mirus Bio LLC is a life science company focused on discovering, developing and commercializing innovative nucleic acid-based technologies and products. Mirus was founded on the principle that non-viral (i.e. plasmid DNA based) methods offer distinct advantages over viral methods of gene transfer. Following this path, Mirus has pioneered the development of a wide range of non-viral delivery technologies using proteins, polymers, and lipids in conjunction with novel chemistries that provide unique nucleic acid delivery capabilities.